Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
14.05.How to manage the complexities of synthetic API production in 30 steps
14.05.GSK to spend $2bn on Phase III liver disease drug acquisition
14.05.Stylus Medicine launches with $85m to advance in vivo gene editing
14.05.Eligo Bioscience secures grant to advance topical gene delivery platform
14.05.GSK and iTeos drop anti-TIGIT drug following trial failure
14.05.Japan's MHLW approves Sarepta's gene therapy for DMD
13.05.Orphan drug market access in Europe: HTA challenges and the growing potential of RWE
13.05.Reducing patient burden in rare disease trials: DCTs for increased patient centricity
13.05.FDA clears Ensoma's application for rare genetic disorder treatment
13.05.How to transform EHR data into useful clinical insights using AI
13.05.Pharma faces 30-day deadline under Trump's pricing order
13.05.EC grants orphan drug status to Biodexa's oral FAP treatment
13.05.Republicans' proposed Medicaid cuts met with dismay
13.05.Abeona secures cash runway with $155m priority review voucher sale
13.05.GLP-1RAs show anti-cancer benefits beyond weight loss
13.05.MHRA approves AstraZeneca's Trixeo Aerosphere inhaler for COPD
12.05.Roche plans $700m manufacturing plant in the US
12.05.Novo Nordisk's Sogroya matches Norditropin in children's growth disorders
12.05.Minghui and Qilu Pharmaceutical to advance MHB088C in Greater China
12.05.The advantages of isolator lines for large-scale pharma manufacturing
12.05.Trump to sign order tying US drug prices to global rates
12.05.LENZ and Lotus Pharmaceutical collaborate to commercialise presbyopia treatment
12.05.Valneva's chikungunya vaccine use halted in older adults amid safety concerns
12.05.Lilly-Purdue partnership to invest $250m in pharma innovation
12.05.American Academy of Neurology (AAN) Annual Meeting 2025